ArticleJournal of the Korean Society of Radiology2025
Occult Breast Cancer Initially Presenting with Axillary Lymph Node Metastasis: A Case Report.
Article in Journal of the Korean Society of Radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Occult breast cancer presenting with axillary lymph node metastasis refers to carcinoma of unknown primary origin that is consistent with metastatic breast cancer initially presenting with axillary metastasis, without clinical or imaging evidence of a definitive primary breast tumor. The standardized treatment and prognosis of occult breast cancer remain unknown owing to its rarity. Herein, we report a case of a 59-year-old woman with occult breast cancer who presented with axillary metastasis. A comprehensive evaluation, including a thorough review of breast examination findings such as mammography and ultrasonography, breast MRI, lymph node biopsy with immunohistochemistry analysis, additional whole-body PET-CT, and testing for other tumor markers, can be crucial in diagnosing occult breast cancer. Therefore, effective communication among clinicians, radiologists, and pathologists throughout the diagnostic process, along with clear explanations to patients, is crucial for diagnosing this rare occult breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.